21.02.2017
- AstraZeneca has agreed to sell the commercial rights for its cancer treatment Zoladex in the US and Canada for $250 million upfront to private equity-backed TerSera Therapeutics –...
16.02.2017
- The UK’s Tusk Therapeutics is joining Cancer Research Technology (CRT) and University College London (UCL) to research, develop and commercialize an antibody-based therapeutic...
10.02.2017
- US biomedical company Q BioMed has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and India’s Rajiv Gandhi Centre for Biotechnology to develop a...
06.02.2017
- American Chemistry Council (ACC), the association representing US chemical producers, has launched a public campaign aimed at debunking claims made by the Lyon, France-based...
30.01.2017
- About 20% of all new drugs will be rationed under tighter cost-cutting plans in the UK’s National Service (NHS), according to reports, which suggest that patients who suffer from...
12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
20.12.2016
- Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...
08.11.2016
- Cancer Research UK is aligning with the Wellcome Trust and investment groups Syncona and BACIT to create a new company with assets of up to £1 billion that will invest in life...
